Software-based Fusion of PET and CT Images for Suspected Recurrent Lung Cancer
- First Online:
- 75 Downloads
The purpose of this study was to compare the diagnostic performance of the manual fusion of positron emission tomography (PET) and computed tomography (CT) images with that of CT alone and that of side-by-side PET and CT (PET/CT) in patients with suspected recurrent lung cancer.
Fifty-three patients who had previously had surgery for lung cancer underwent a whole-body 2-deoxy-2-[F-18]fluoro-d-glucose (FDG)-PET scan, followed by a diagnostic CT scan. The PET and CT images were fused on a workstation. CT alone, PET/CT, and fused images were evaluated separately using a five-point grading scale (0 = definitely negative, 1 = probably negative, 2 = equivocal, 3 = probably positive, and 4 = definitely positive). Lesions of grade 3 or 4 were considered positive, and diagnostic accuracy and certainty were evaluated.
Overall, 67 lesions in 33 patients were considered true positive pathologically or clinically. Of these 67 lesions, the evaluation of CT, PET/CT, and fused images detected 46, 55, and 66 lesions, respectively, with the number of grade 4 lesions detected being 38, 50, and 63, respectively. The diagnostic accuracy of CT, PET/CT, and fused images according to patients was 75%, 79%, and 87%, respectively.
These results suggest that interpreting fused images increased diagnostic certainty for detecting recurrence and provided more accurate diagnoses.
Key wordsFDG PET CT Lung cancer Recurrence
- 13.Nakamoto Y, Sakamoto S, Okada T et al. (2005) Accuracy of image fusion using a fixation device for whole-body cancer imaging. Am J Roentgenol 184:1960–1966Google Scholar
- 14.Toorongian SA, Mulholland GK, Jewett DM, Bachelor MA, Kilbourn MR (1990) Routine production of 2-deoxy-2-[18F]fluoro-D-glucose by direct nucleophilic exchange on a quaternary 4-aminopyridinium resin. Int J Radiat Appl Instrum B 17:273–279Google Scholar
- 21.van Der Wel A, Nijsten S, Hochstenbag M et al. (2005) Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study. Int J Radiat Oncol Biol Phys 61:649–655Google Scholar